Current Therapy of Type 2 Diabetes Mellitus using a Sample of SulfonylureaG — Prolonged Releasing Gliclazide Produced by Pharmak, Ltd (Kyiv, Ukraine)

Abstract

The paper describes the efficacy of sulfonylurea derivative — domestic medication Dіaglizide MR (Farmak, Ltd) in the treatment of type 2 diabetes mellitus. The efficacy and safety of the agent confirmed in scientific studies allow recommend it for the treatment of type 2 diabetes mellitus.

Keywords

• type 2 diabetes mellitus
• Diaglizide MR
• endothelial dysfunction